Cloud Foundations for R&D: Designing the Future of Life Sciences
In recent years, artificial intelligence has been hailed as the next big thing in drug…
31/08/2021 - 7 minutes
Opinion
Opinion-based articles written by experts working across different areas of the European biotechnology industry.
ADVERTISEMENT
Do you want to remove this advert? Become a member!
Investors Turn to Biotechnology for a Sustainable Future
The next industrial revolution is going to be a bio-revolution. It has to be, given…
11/08/2021 - 6 minutes
The Underlying Scientific Issues Making Biotech Startups Fail
Biotech startups rely heavily on the science behind their products. There are a series of…
26/07/2021 - 5 minutes
Three Lessons an Investor Can Learn from Biotech Entrepreneurs
Sofinnova Partners’ Chairman and Managing Partner, Antoine Papiernik, describes his company’s ‘Wall of Fame’ showcasing…
07/07/2021 - 7 minutes
A Window to the Past: Is the Biotech Investment Boom Going to Last?
The biotech industry has been going through a period of fast growth in recent years.…
21/06/2021 - 7 minutes
How Good Investor Communications Determine Success in a Covid World
During the pandemic, the biotech industry has continued to complete deals, even without face-to-face interactions.…
26/04/2021 - 6 minutes
The Hidden Costs of Mismanaged R&D Projects in Biotech and Pharma
Mismanagement of R&D projects in biotech and pharma is more common than one might think…
19/04/2021 - 7 minutes
Advice for my Younger Self: How to Be a VC in Life Sciences
Antoine Papiernik, Chairman and Managing Partner at Sofinnova Partners, looks back at where he was…
08/03/2021 - 5 minutes
How Culture Impacts Biotech Investment
Culture influences your choices about money. This applies in normal life, but also in the…
29/10/2019 - 8 minutes
Can European Biotech Companies Afford Not to Work with China?
In the current trade standoff between the US and China, Europe has a golden opportunity…
30/09/2019 - 4 minutes
The Business of Biotech: What to Do When the S*#t Hits the Fan
From CEO-itis to FDA-itis, the path of a biotech company is never dull. Whether the…
16/07/2019 - 5 minutes
Is Going Public in Europe the Kiss of Death?
The key for a European biotech is to find the money where it is. And…
05/06/2019 - 6 minutes
